Literature DB >> 15794974

Neonatal survival: a call for action.

Jose Martines1, Vinod K Paul, Zulfiqar A Bhutta, Marjorie Koblinsky, Agnes Soucat, Neff Walker, Rajiv Bahl, Helga Fogstad, Anthony Costello.   

Abstract

To achieve the Millennium Development Goal for child survival (MDG-4), neonatal deaths need to be prevented. Previous papers in this series have presented the size of the problem, discussed cost-effective interventions, and outlined a systematic approach to overcoming health-system constraints to scaling up. We address issues related to improving neonatal survival. Countries should not wait to initiate action. Success is possible in low-income countries and without highly developed technology. Effective, low-cost interventions exist, but are not present in programmes. Specific efforts are needed by safe motherhood and child survival programmes. Improved availability of skilled care during childbirth and family/community-based care through postnatal home visits will benefit mothers and their newborn babies. Incorporation of management of neonatal illness into the integrated management of childhood illness initiative (IMCI) will improve child survival. Engagement of the community and promotion of demand for care are crucial. To halve neonatal mortality between 2000 and 2015 should be one of the targets of MDG-4. Development, implementation, and monitoring of national action plans for neonatal survival is a priority. We estimate the running costs of the selected packages at 90% coverage in the 75 countries with the highest mortality rates to be US4.1 billion dollars a year, in addition to current expenditures of 2.0 billion dollars. About 30% of this money would be for interventions that have specific benefit for the newborn child; the remaining 70% will also benefit mothers and older children, and substantially reduce rates of stillbirths. The cost per neonatal death averted is estimated at 2100 dollars (range 1700-3100 dollars). Maternal, neonatal, and child health receive little funding relative to the large numbers of deaths. International donors and leaders of developing countries should be held accountable for meeting their commitments and increasing resources.

Entities:  

Mesh:

Year:  2005        PMID: 15794974     DOI: 10.1016/S0140-6736(05)71882-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  95 in total

1.  Are cost effective interventions enough to achieve the millennium development goals?

Authors:  Suwit Wibulpolprasert; Viroj Tangcharoensathien; Churnrurtai Kanchanachitra
Journal:  BMJ       Date:  2005-11-12

Review 2.  Towards millennium development goal four.

Authors:  M Ellis; S Allen
Journal:  Arch Dis Child       Date:  2006-09       Impact factor: 3.791

Review 3.  Vaccination greatly reduces disease, disability, death and inequity worldwide.

Authors:  F E Andre; R Booy; H L Bock; J Clemens; S K Datta; T J John; B W Lee; S Lolekha; H Peltola; T A Ruff; M Santosham; H J Schmitt
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

4.  Evaluation of the impact of the Family Health Program on infant mortality in Brazil, 1990-2002.

Authors:  James Macinko; Frederico C Guanais; Maria de Fátima; Marinho de Souza
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

5.  Association between birth attendant type and delivery site and perinatal outcomes.

Authors:  Albert Manasyan; Elwyn Chomba; Janet Moore; Dennis Wallace; Elizabeth M McClure; Marion Koso-Thomas; Waldemar A Carlo
Journal:  Int J Gynaecol Obstet       Date:  2019-03-08       Impact factor: 3.561

6.  Premature delivery and the millennium development goal.

Authors:  Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2012

7.  Deployment of community health workers across rural sub-Saharan Africa: financial considerations and operational assumptions.

Authors:  Gordon C McCord; Anne Liu; Prabhjot Singh
Journal:  Bull World Health Organ       Date:  2013-02-13       Impact factor: 9.408

8.  The APPLe study: a randomized, community-based, placebo-controlled trial of azithromycin for the prevention of preterm birth, with meta-analysis.

Authors:  Nynke R van den Broek; Sarah A White; Mark Goodall; Chikondi Ntonya; Edith Kayira; George Kafulafula; James P Neilson
Journal:  PLoS Med       Date:  2009-12-01       Impact factor: 11.069

Review 9.  Advancing newborn health: The Saving Newborn Lives initiative.

Authors:  A Tinker; R Parker; D Lord; K Grear
Journal:  Glob Public Health       Date:  2010

10.  Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.

Authors:  Shahnaz Ibrahim; Shamshad Gulab; Sidra Ishaque; Taimur Saleem
Journal:  BMC Pediatr       Date:  2010-01-15       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.